ABSTRACT Trophoblastic cell fusion is one essential step of the human trophoblast differentiation pathway and is a multifactorial and dynamic process finely regulated and still poorly known. Disturbances of syncytiotrophoblast formation are observed in numerous pathological clinical conditions such as preeclampsia, intrauterine growth retardation and trisomy 21. In this review, we summarize current knowledge of the different membrane proteins directly involved in trophoblastic cell fusion, which we identified by using the physiological model of primary culture of villous trophoblastic cells. Connexin 43 and gap junctional intercellular communication point to the role of molecular exchanges through connexin channels preceding membrane fusion. Zona occludens-1, which can interact with connexin 43, is also directly involved in trophoblast fusion. The recently identified fusogenic membrane retroviral envelop glycoproteins syncytin 1 (encoded by the HERV-W gene) and syncytin 2 (encoded by the FRD gene) and their receptors are major factors involved in human placental development . We describe the increasing number of factors promoting or inhibiting trophoblast fusion and differentiation and emphasize the role of human chorionic gonadotropin (hCG) and its receptor. Indeed, in trisomy 21 the dynamic process leading to membrane fusion is impaired due to an abnormal hCG signaling. This abnormal trophoblast fusion and differentiation in trisomy 21-affected placenta is reversible in vitro. Trisomy 21 trophoblastic cell culture may therefore be useful to identify the possible large number of prerequisite factors involved in trophoblast fusion, the limiting step of trophoblast differentiation.
In the human placenta, the trophoblast differentiates along two major pathways both critical for normal placental functions (Benirschke and Kaufmann, 2000) . In the extravillous trophoblast invasive pathway, the cytotrophoblastic cells of the anchoring villi in contact with the uterus wall proliferate, detach from the basement membrane and aggregate into multilayered columns of nonpolarized cells that invade the uterus wall (Fig.1) . These cells, which compose the extravillous cytotrophoblast (ECT), invade the endometrium, the first third of the myometrium and the associated spiral arterioles. In the villous trophoblast pathway, the cytotrophoblastic cells (CT) of the floating villi proliferate, differentiate and fuse to form a syncytiotrophoblast (ST) that covers the entire surface of the villi (Fig.1) . The syncytiotrophoblast layer plays a major role throughout pregnancy, since it is the site of numerous placental functions, including ion and nutrient exchange and the synthesis of steroid and peptide hormones required for fetal growth and development (Eaton and Contractor, 1993; Ogren and Talamentes, 1994) . Among them, progesterone and hCG (human Chorionic Gonadotropin) are absolutely required for human gestation. Therefore, disturbances of syncytiotrophoblast formation or functions are observed in pathological clinical conditions such as preeclampsia (Langbein et al., 2008) and trisomy 21 (Frendo et al., 2004; Frendo et al., 2000b; Massin et al., 2001; Pidoux et al., 2007a; Pidoux et al., 2004b) and may be implicated in abnormal fetal growth and development.
The multinucleated syncytiotrophoblast is regenerated along pregnancy by a continuous turnover process including proliferation of mononuclear CT followed by the induction of early stages of apoptosis and fusion of these CT into ST. Apoptotic progres-sion in the ST leads to the accumulation of condensed nuclei into syncytial knots and the shedding of these aggregates into the intervillous spaces. Syncytiotrophoblast formation can be reproduced in vitro using different models. Choriocarcinoma cells, ie BeWo cells, are able to fuse in presence of cAMP to form a multinucleated syncytium. However, the last step of differentiation, the gathering of nulei into a central mount, is missing. In addition, these cells are transformed and some trophoblastic functions are not present (King et al., 2000) . Denude villous explants from early placenta allow to follow the in vitro ST repairing. In this model, the cell-cell interactions are present, but cell-cell communication studies and quantification of trophoblastic hormones are difficult to assess. Purified villous CT, cultured on plastic dishes, aggregate and fuse forming the multinucleated ST ( Fig. 2A) with pregnancy specific hormonal production (ie hCG, Progesterone) (Kliman et al., 1986) . This model allows accurate biochemical studies.
Due to the key role of trophoblastic cell fusion in human pregnancy, we tried to identify the membrane proteins directly implicated in the ST formation (in normal and pathological conditions) using the physiological model of villous trophoblastic cells primary culture. The Trisomy 21 (T21) affected trophoblast model of abnormal fusion and differentiation allowed us to unravel the major factors involved in these processes.
Membrane proteins involved in trophoblastic cell fusion
Before two cells can fuse, several steps are needed. Firstly, the cells must leave the proliferative stage and express genes and proteins involved in the fusion process. Secondly, they must recognize and interact to their fusion partner. Thirdly, the cells must communicate together, allowing signals exchange. Lastly, they can fuse. Therefore, this dynamic process may be finely regulated and coordinated.
The identification of a protein directly involved in trophoblastic cell fusion, requires not only the localization of this protein at the membrane level during one step of the process, but also to demonstrate that the knock-down of it synthesis (siRNA or antisense strategy) induces an inhibition or a decrease of trophoblastic cell fusion.
During last years, we used the physiological model of villous CT primary culture to analyze the expression and the role of different membrane proteins in trophoblast fusion. Cells were isolated from first, second trimester and term placentas. Protein expression, mRNA and cellular localization of connexin 43, zona occludens-1 (ZO-1), syncytin 1 (HERV-W envelop glycoprotein) and syncytin 2 (HERV-FRD envelop glycoprotein) were analyzed during the different steps of villous trophoblastic cells differentiation: isolated cells, aggregated cells, fused cells.
Connexin 43 and Gap Junctional Intercellular Communication (GJIC)
Gap junctions are clusters of trans-membrane channels composed of connexin (Cx) hexamers. Gap junctions provide pathway for the diffusion of ions and small molecules such as cAMP, cGMP, inositol triphosphate and Ca 2+ . Connexins represent a family of closely related membrane proteins, which are encoded by a multigene family that contains at least 20 members in humans. These connexins have different biophysical properties, functional and regulatory characteristics (Willecke et al., 2002) . The permeability of junctional channels is finely regulated. This regulation involves the cyclic phosphorylation and dephosphorylation of connexins and changes in intracellular Ca 2+ , H + and cAMP. The exchange of molecules through gap junctions is thought to be involved in the control of cell proliferation, in the control of cell and tissue differentiation, in metabolic cooperation and in spatial compartimentalization during embryonic development (BaniYaghoub et al., 1999; Lecanda et al., 1998; Loewenstein, 1981; Saez et al., 1993) . Furthermore other effects of connexins expression have been attributed to the interaction of Cx to the intracellular signal cascades via the carboxy-terminus (Herve et al., 2004) .
We have previously demonstrated, both in situ and in vitro the expression of Cx43 mRNA in villous trophoblast and the localization of Cx43 protein between CTs and between CTs and ST whereas Cx26, Cx32, Cx33 and Cx40 were not detected. Furthermore, using fluorescence recovery after photobleaching method (gap-FRAP) we demonstrated the presence and the requirement of a functional inter trophoblastic communication via gap junctions (Cronier et al., 1994; Malassine and Cronier, 2005) . Futhermore, cultured CT treated with Cx43 antisense aggregate and fuse poorly. This treatment dramatically reduces the percentage of coupled cells as demonstrated by the gap-FRAP method (Frendo et al., 2003a) . This demonstrates that the molecular exchanges through connexins channels, preceding membrane fusion, are one essential step for trophoblastic cell fusion.
Zona occludens-1 (ZO-1)
Secondary proteins interacting with connexins have been iden- tified: chaperones, scaffolding proteins, kinases, phosphatases, cells signaling molecules (for review see Herve et al., 2004) . Among these partner proteins, zona occludens-1 (ZO-1) has been demonstrated to interact with multiple connexins. ZO-1 is a 220 kDa peripheral membrane protein, which has been originally identified in association with tight junction (Anderson et al., 1988; Stevenson et al., 1986 ) and later at adherens junction. ZO-1 contains multiple protein interaction domains including three PSD95/Dlg/ZO-1 (PDZ) domain and a Src homology 3 (SH3) domain (Anderson et al., 1988; Beatch et al., 1996; Itoh et al., 1993; Willott et al., 1993) . A recent study using nuclear magnetic resonance method, demonstrated that the interaction of Cx43 with ZO-1 occurs through the last 20 amino acids in the extreme carboxyl terminus of Cx43 and the second PDZ domain of ZO-1 (Giepmans and Moolenaar, 1998; Sorgen et al., 2004) . Divergent roles have been proposed for the interaction of ZO-1 and Cx43. Changes in Cx43-ZO-1 interaction have been noted during remodeling of gap junctions in different cell types (Barker et al., 2002; Defamie et al., 2001; Segretain et al., 2004) . Modulation of Cx43 and ZO-1 interactions may also be involved in gap junction formation, localization and activity Giepmans et al., 2001; Hunter et al., 2005; Sorgen et al., 2004; Toyofuku et al., 2001) . A role in internalization and remodeling of Cx43 in response to intracellular changes (Barker et al., 2002) and in targeting for endocytosis (Segretain et al., 2004) was also demonstrated. Therefore, we have investigated the role of ZO-1 in the trophoblastic cell fusion process. In situ, ZO-1 and Cx43 immunocolocalized at some intercellular boundaries, between CTs and between CTs and ST. During in vitro trophoblast differentiation ZO-1 was localized only at the intercellular boundaries of aggregated cells and its expression decreased. Cx43 expression had the same localization but its expression increased during differentiation. Cx43 and ZO-1 co-localized only at some intercellular boundaries of aggregated cells (Fig. 2B left panel) . Moreover, by using co-immunoprecipitation experiments, a physical interaction between ZO-1 and Cx43 was demonstrated. To determine a functional role for ZO-1 during trophoblast differentiation a siRNA strategy was used to knock-down ZO-1 expression. CTs treated with ZO-1 siRNA aggregated but fused poorly and less hCG secretion was detected. Furthermore, Cx43 expression was decreased in ZO-1 siRNA treated CTs. Moreover, this treatment did not alter the functionality of trophoblastic cell-cell communication assessed by Gap-Frap method. These results demonstrate that ZO-1 expression is required for trophoblastic cell fusion.
Fusogenic membrane retroviral envelop glycoproteins: syncytin 1 and 2
Human endogenous retroviruses (HERV) comprise approximately 8% of the human genome (de Parseval and Heidmann, 2005; Lander et al., 2001) . Most of the identified elements are defective due to mutations and/or deletions within their genes, but some elements have conserved intact open reading frames. A systematic search for non-defective endogenous retrovirus envelope genes has led to the identification of 16 genes . Among them two can induce cell-cell fusion when expressed in different cells and are highly and specifically expressed in the human placenta (Blaise et al., 2003; Blond et al., 2000; Mi et al., 2000) .
The products of these two genes are glycoproteins named HERV-W Env glycoprotein (syncytin 1) and HERV-FRD Env glycoprotein (syncytin 2). Syncytin 1 and syncytin 2 originate from distinct retroviral elements, and disclose several differences. Syncytin 2 entered the primate genomes earlier than syncytin 1, namely before the split between New World and Old World Monkeys (i.e > 40 Myrs ago), whereas syncytin 1 entered about 25 Myrs ago, being not found in Old World Monkeys. Yet, both genes remained functional in all the corresponding primate branches, thus strongly suggesting selection for a physiological role. Syncytin 1 and syncytin 2 also differ by their receptor (still not identified for syncytin 2), as demonstrated by ex vivo cell-cell 
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fusion assays using different cell types. In addition it has been shown recently that syncytin 2 is immunosuppressive and syncytin 1 is not (Mangeney et al., 2007) . We first demonstrated using monoclonal and polyclonal antibodies that in situ syncytin1 is immunolocalized in all cell type of human trophoblast: villous and extravillous trophoblast. Syncytin 1 is fusogenic by interacting with the D type mammalian retrovirus receptor (RDR) also known to be the neutral amino acid transporter ATB0/ASCT2/SLC1A5. We showed that the D type mammalian retrovirus receptor is also localized in the various trophoblastic phenotypes .
We analysed the involvement of syncytin 1 in the differentiation of CT in culture. First, the syncytin 1 mRNA and glycoprotein expressions were found to increase with cell aggregation and fusion and then to slightly decrease (Fig. 2C) . Second, in vitro stimulation of trophoblast cell fusion and differentiation by cAMP is associated with a concomitant increase in syncytin 1 and hCG mRNAs and protein expression as well. Finally, we demonstrated by using specific antisense oligonucleotides that inhibition of syncytin1 expression lead to a decrease of trophoblast fusion and differentiation (Frendo et al., 2003b) , hCG secretion in the culture medium of antisense treated cells being decreased by 5 fold. Furthermore the inhibition of trophoblast fusion by overexpression of superoxide dismutatse 1 (SOD-1) is associated with an absence of increase in HERV-W env mRNA Frendo et al., 2000a) .
All together, these results strongly support a direct role of syncytin1 in human trophoblastic cell fusion and differentiation. However, the co-localization of syncytin1 and its receptor in trophoblastic cells that do not fuse (extravillous trophoblast) (Muir et al., 2006) suggests that syncytin1 and its receptor appear to be required but not sufficient for trophoblastic cell fusion.
We then studied the expression of syncytin2 in human placenta. In situ, syncytin 2 immunolocalization is restricted to some CT of the villous trophoblast. Furthermore, this localization highlights the modification of CT shape from cuboïdal in early placenta to flat with cytoplasmic processes in term placenta (Malassine et al., 2008) . In vitro, syncytin 2 is only observed in some aggregated CTs, with stronger staining at intercellular sites (Fig. 2C) . Syncytin 2 transcript levels decrease significantly upon CT fusion into ST in culture (Fig. 2D) . Syncytin 2 is highly fusogenic when overexpressed by transfection in various cultured cells, however its role in villous trophoblastic fusion has not been yet demonstrated.
Kinetics of expression of Cx43, ZO-1 and syncytins during syncytiotrophoblast formation
Expression of these proteins at the right time to correct place is a challenge for the CT fusion. Therefore the evolution of Cx43, ZO-1 as well as syncytin 1 and 2 expression was analyzed during in vitro trophoblast differentiation.
As shown in Fig. 2C it appears that syncytin 2 and ZO-1 are highly expressed in isolated CTs and their expression rapidly decrease during ST formation. On the other hand, syncytin1 and Cx43 mRNA increase with cell aggregation and fusion and then slightly decrease. Proteins expression follows the same pattern (data not shown). These results are in agreement with the fact that Cx43 and ZO-1 are mainly co-localized during the aggregation stage at 48 hours of culture. In addition, these results illustrate the striking difference in syncytin1 and 2 localization: syncytin 2 only in some CT and syncytin 1 in all CT and ST. Trisomy of chromosome 21 (T21), which causes the phenotype known as Down syndrome, is the major known genetic cause of mental retardation and is found in around 1:800 live births. Little is known about placental development in this aneuploid condition. However, a defect in syncytiotrophoblast formation in T21-affected placentas is observed. Cultured cytotrophoblasts, isolated from T21-affected placentas, aggregate but fuse poorly or belatedly (Frendo et al., 2000b; Massin et al., 2001) . This is in agreement with previous histological observations pointing to an increased percentage of two layered trophoblast in T21 placentas (Oberweiss et al., 1983; Roberts et al., 2000) (Fig. 3A) . In addition, we demonstrated that this in vitro defect or delay in syncytiotrophoblast formation is characterized by a dramatic decrease in the synthesis of syncytiotrophoblastic pregnancy-associated hormones (Pidoux et al., 2004a) and by the secretion of an hyperglycosylated hCG with low bioactivity (Frendo et al., 2004) . This abnormal trophoblast fusion implicates at least in part overexpression of SOD-1 (Frendo et al., 2002) . In addition we recently showed that during the second trimester of pregnancy, syncytin 2 is immunolocalized in some cuboidal CTs in T21 placentas, whereas in normal placentas it is observed in flat CTs extending into their cytoplasmic processes. These results highlight the abnormal trophobalst differentiation observed in trisomy 21 affected placentas.
As shown in figure 3B , CT isolated from T21 affected placenta, aggregate normally but do not fuse or fuse poorly. In these cells, transcript levels of Cx 43, ZO-1, syncytin1 and 2 do not vary with time in culture (Fig. 3C) . Proteins expression follows the same pattern (data not shown).
In contrast, in normal CT the decrease of ZO-1 and syncytin1 and the increase of Cx43 and Syncytin 2 expression are associated with cell-cell fusion. This highlights that the timely regulated expression of these proteins seems to be required for normal trophoblast fusion.
Other factors involved in trophoblastic cell fusion
During last years, in different in vitro models such as BeWo cells and explants culture other factors have been described to be directly involved in trophoblastic cell fusion: the phosphatidylserine (Adler et al., 1995) , cadherin 11 (Getsios and MacCalman, 2003) , CD 98 (Dalton et al., 2007) , caspase 8 (Black et al., 2004) , ADAMs12 (Huppertz et al., 2006) . Phosphatidylserine flip is a phospholipid normally confined to the inner layer of the plasma membrane but prior to fusion this translocates to the outer layer and facilitates inter-membrane fusion. According to Huppertz and Kingdom (Huppertz and Kingdom, 2004) , this phosphatidylserine flip is a consequence of activation of initiator caspase (caspase 8) leading to the concept that the molecular machinery of early apoptosis is involved in the fusion process. ADAM 12 (meltrin alpha) is a disintegrin and metalloprotease involved in myoblast fusion and CD 98 is an integral membrane protein with N-linked glycosylation sites known to be important for adhesion, aminoacid transport and cell-cell fusion as well as virus induced cell fusion. Manipulations of CD98 expression by antisense oligonucleotide and small interfering RNA affect both amino acid transport and cell fusion in BeWo cells (Kudo et al., 2003) . Furthermore, primary CTs cultured in the presence of antisense oligonucleotides specific for cadherin-11 a cell adhesion molecule, do not undergo terminal differentiation and fusion with time in culture (Getsios and MacCalman, 2003) . In the present study we show for the first time that the expression of some factors required for trophoblast fusion are timely regulated. Indeed it is conceivable that cells must be joined by tight junctions and adherens junctions prior to establish gap junctions, gap junctionnal communication and to initiate membrane fusion. This latest process is facilitated by the syncytins which might form bundles of alpha-helices similar to the class 1 viral fusion protein that bring membranes close together (Larsson et al., 2008) .
On the other hand, an increasing number of factors promoting or inhibiting trophoblastic cell fusion and differentiation is described through the literature and summarized in Table 1. They are described to modulate in vitro the ST formation in primary cultures of villous CT, and they illustrate the numerous signaling pathways implicated in trophoblast differentiation. However little is known on the role of these soluble factors on the expression, the membrane localization and /or the interaction of the different identified partners of cell fusion.
Among these factors, hCG might be the major one. Since the study of Shi et al. (Shi et al., 1993) demonstrating that hCG has a direct role in trophoblast differentiation, different studies have confirmed the importance of hCG and its membrane receptor in syncytiotrophoblast formation (Pidoux et al., 2007a; Pidoux et al., 2007b; Shi et al., 1993) . The hCG receptor, which has seven transmembrane domains, belongs to the superfamily of G protein-coupled receptors (Loosfelt et al., 1989; McFarland et al., 1989; Minegishi et al., 1990; Pierce and Parsons, 1981) . HCG binding to its receptor activates adenylate cyclase, phospholipase C and ion channels, which in turn control cellular cAMP, inositol phosphates, Ca 2+ and other secondary messengers (Gudermann et al., 1992; Hipkin et al., 1992) . Agents increasing
Stimulation action
Inhibiting action EGF (Alsat et al., 1993; Morrish et al., 1987) hCG (Cronier et al., 1994; Shi et al., 1993) cAMP (Cronier et al., 1997b; Keryer et al., 1998) GM-CSF (Garcia-Lloret et al., 1994) Macrophages and macrophage-conditionned media (Cervar et al., 1999; Khan et al., 2000) Dexamethasone (Cronier et al., 1998) Estradiol (Cronier et al., 1999b) TGF-β1 (Cronier et al., 1997a; Morrish et al., 1991) LIF (Nachtigall et al., 1996) Hypoxia, SOD-1 (Alsat et al., 1996; Frendo et al., 2001; Frendo et al., 2000a; Levy et al., 2000) Endothelin (Cronier et al., 1999a) 15ΔPGJ2 (Levy et al., 2000) TNFα (Leisser et al., 2006) (Keryer et al., 1998) and also elevate mRNA levels of syncytin1 in cultured trophoblasts (Frendo et al., 2003b) . Interestingly syncytin 1 was shown to be a target gene of GCMa, a placenta specific transcription factor that is required for placental development in mouse (Schreiber et al., 2000) . GCMa, which possesses two PKA phosphorylation sites might be phosphorylated by PKA inducing a stimulation of its transcriptional activity and therefore syncytin1 expression (Knerr et al., 2005) . Interestingly, we recently demonstrated that Trisomy 21 affected trophoblastic cells produce abnormally glycosylated forms of hCG with low biological activity (Frendo et al., 2004) . Furthermore, these cells express a low number of hCG/LH receptors (Pidoux et al., 2007a) . Endly, we demonstrated that the in vitro defect of ST formation in T21 is reversible when CT are treated with biosynthetic hCG (Pidoux et al., 2007a) . These results confirm in a pathological model the major role of hCG and its receptor in trophoblast fusion and differentiation.
Concluding remarks
Trophoblast fusion is one essential step of the trophoblast differentiation pathway and is a multifactorial and dynamic process finely regulated and still poorly known. We and others are just at the beginning of the identification of possibly a large number of prerequisite factors for this process. The recently identified retroviral envelop glycoproteins (syncytins), highly fusogenic proteins, appear to play a major role. Identification of syncytin 2 receptor will allow us a better understanding of its exact role in placental development. In addition our results point to the fact that abnormal trophoblast fusion and differentiation in T21-affected placenta is reversible in vitro.
